Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD

Contraception

Volumn 80, Issue 1, 2009, Pages 63-67

  Rifkin, Samara B ^a   Smith, Marsha R ^b,c   Brotman, Rebecca M ^a,d   Gindi, Renee M ^a   Erbelding, Emily J ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BALTIMORE CITY HEALTH DEPARTMENT   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial vaginosis; Case crossover analysis; Combined hormonal contraception; Depot medroxyprogesterone acetate (DMPA); Generalized estimating equations (GEE); Progestin only contraception

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; FEMALE; HERPES SIMPLEX; HORMONAL CONTRACEPTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; VAGINITIS;

ADULT; AMBULATORY CARE FACILITIES; BALTIMORE; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; PROGESTINS; PROSPECTIVE STUDIES; RISK ASSESSMENT; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 67349086963     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.01.008     Document Type: Article

References (30)

1. Koumans E.H., Sternberg M., Bruce C., et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behavior, and reproductive health. Sex Transm Dis 34 (2007) 864-869
2. Wawer M.J., Sewankambo N.K., and Serwadda D. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 353 (1999) 525-535
3. Koumans E.H., Kendrick J.S., and CDC Bacterial Vaginosis Working Group. Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. Sex Transm Dis 28 (2001) 292-297
4. Fredricks D.N., Fielder T.L., and Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353 (2005) 1899-1911
5. Schwebke J.R., and Desmond R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex Transm Dis 32 (2005) 654-658
6. Bradshaw C.S., Morton A.N., Hocking J., et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193 (2006) 1478-1486
7. Larsson P.G. Treatment of bacterial vaginosis. Int J STD AIDS 3 (1992) 239-247
8. Sobel J.D., Schmitt C., and Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis 167 (1993) 783-784
9. Austin M.N., Beigi R.H., Meyn L.A., et al. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 43 (2005) 4492-4497
10. Yen S., Shafer M.A., Moncada J., et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 102 (2003) 927-933
11. Calzolari E., Masciangelo R., Milite V., et al. Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70 (2000) 341-346
12. Avonts D., Sercu M., Heyerick P., et al. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 17 (1990) 23-29
13. Barbone F., Austin H., Louv W.C., et al. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol 163 (1990) 510-514
14. Baeten J.M., Nyange P.M., Richardson B.A., et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185 (2001) 380-385
15. Riggs M., Klebanoff M., Nansel T., et al. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis 34 (2007) 954-959
16. Brotman R.M., Erbelding E.J., Jamshidi R.M., et al. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol 20 (2007) 225-231
17. Amsel R., Totten P.A., Spiegel C.A., et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
18. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
19. Wilson J.D., Lee R.A., Balen A.H., et al. Bacterial vaginal flora in relation to changing oestrogen levels. Int J STD AIDS 18 (2007) 308-311
20. Boskey E.R., Cone R.A., Whaley R.J., et al. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16 (2001) 1809-1813
21. Brabin L., Fairbrother E., Mandal D., et al. Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinics. Sex Transm Infect 81 (2005) 128-132
22. Eschenbach D.A., Patton D.L., Meier A., et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 62 (2000) 107-112
23. Miller L., Patton D.L., Meier A., et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 96 (2000) 431-439
24. Hay P.E., Ugwumadu A., and Chowns J. Sex, thrush and bacterial vaginosis. Int J STD AIDS 8 (1997) 603-608
25. Schwebke J.R., Richey C.M., and Weiss H.L. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 180 (1999) 1632-1636
26. Keane F.E., Ison C.A., and Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 8 (1997) 489-494
27. Sobel J.D. Vaginitis. N Engl J Med 337 (1997) 1896-1903
28. Spiegleman D., and Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162 (2005) 199-200
29. Holzman C., Leventhal J.M., Qui H., et al. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 91 (2001) 1664-1670
30. Mosher W.D., Martinez G.M., Chandra A., et al. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 350 (2004) 1-36